Ginsenoside Rk1 Ameliorates Non-Alcoholic Fatty Liver Disease by Targeting CD36 to Modulate the AMPK Signaling Pathway - Yuqing Wu; Zhiguang Duan; Linlin Qu; Yannan Liu; Xiaoxuan Ma; Daidi Fan (Food Research International, 2025)